Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The us...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
IMA-PRESS LLC
2012-09-01
|
| Series: | Современная ревматология |
| Assuntos: | |
| Acceso en liña: | https://mrj.ima-press.net/mrj/article/view/431 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|